0 of 10 questions completed
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading…
You must sign in or sign up to start the quiz.
You must first complete the following:
0 of 10 questions answered correctly
Time has elapsed
You have reached 0 of 0 point(s), (0)
Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)
1.) All of the following are a component of bone quality except:
2.) What is the gold standard to diagnose osteoporosis in ESKD patients?
3.) If CKD-MBD is left untreated, which of the below would be a biochemical abnormality observed?
4.) Which of the following is not a type of renal osteodystrophy?
5.) Parathyroid hormone (PTH) acts on the below target organs to increase serum calcium levels except:
6.) Which of the below pharmacologic agents is used to treat high phosphorus in CKD-MBD?
7.) Which of the following is part of the mechanism of action of denosumab?
8.) The evidence for the use of denosumab in hemodialysis patients is weak and not clinically meaningful because of the following reasons except for:
9.) Which of the following is the most common adverse effect of denosumab?
10.) What is the best way to reduce bone loss and the risk of fractures in patients with ESKD?